Literature DB >> 31044407

PYP or DPD and HDP for cardiac amyloidosis one for all, all for one.

Francesco Cappelli1,2, Chiara Gallini3, Federico Perfetto4.   

Abstract

Entities:  

Year:  2019        PMID： 31044407     DOI： 10.1007/s12350-019-01728-6

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  5 in total

1.  Straightening out the wrinkles in technetium-99m-labeled bone scintigraphy tracer assessment of cardiac amyloidosis.

Authors:  Gary R Small; Terrence D Ruddy
Journal:  J Nucl Cardiol       Date:  2019-04-11       Impact factor: 5.952

2.  Poor right ventricular function is associated with impaired exercise capacity and ventilatory efficiency in transthyretin cardiac amyloid patients.

Authors:  Simone Bartolini; Samuele Baldasseroni; Francesco Fattirolli; Maria Vittoria Silverii; Lucrezia Piccioli; Federico Perfetto; Niccolò Marchionni; Carlo Di Mario; Raffaele Martone; Giulia Taborchi; Sofia Morini; Elisa Vignini; Francesco Cappelli
Journal:  Intern Emerg Med       Date:  2020-09-12       Impact factor: 3.397

3.  Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation.

Authors:  Claire Cuscaden; Stuart C Ramsay; Sandhir Prasad; Bruce Goodwin; Jye Smith
Journal:  J Nucl Cardiol       Date:  2020-05-08       Impact factor: 5.952

4.  Transforming ATTR cardiac amyloidosis into a chronic disease: The enormous potential of quantitative SPECT to improve diagnosis, prognosis, and monitoring of disease progression.

Authors:  Michael P Ayers; Adithya V Peruri; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2021-04-13       Impact factor: 5.952

5.  Quantitation of myocardial 99mTc-HMDP uptake with new SPECT/CT cadmium zinc telluride (CZT) camera in patients with transthyretin-related cardiac amyloidosis: Ready for clinical use?

Authors:  Dimitri Bellevre; Alban Bailliez; François Delelis; Tanguy Blaire; Denis Agostini; Frédéric Mouquet; Sylvestre Maréchaux; Alain Manrique
Journal:  J Nucl Cardiol       Date:  2020-07-26       Impact factor: 5.952
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.